Diabetic Macular Edema Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

 Breaking News
  • No posts were found

Diabetic Macular Edema Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

September 21
11:24 2021
Diabetic Macular Edema Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
DelveInsight Business Research LLP
DelveInsight’s ‘Diabetic macular edema (DME)- Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the DME, historical and forecasted epidemiology as well as the DME market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

DelveInsight has launched a new report on “Diabetic Macular Edema – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Diabetic Macular Edema – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Diabetic Macular Edema, historical and forecasted epidemiology as well as the Diabetic Macular Edema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Diabetic Macular Edema Market Report:

  • As per a population-based study by Li et al. (2020), the prevalence of total diabetes defined by the WHO criteria increased from 9.7% in 2007 to 11.2% in 2017 among adults living in China. These findings indicate that diabetes is an important health problem in China. With growing diabetes cases, DME cases also increase in parallel.

  • Furthermore, In Japan, the total gender-specific diagnosed prevalent cases of DME were 50,717 for males and 36,726 for females, respectively in the year 2020.

  • According to DelveInsight’s analysis, in Japan, the age-specific diagnosed prevalent cases of DME for the age groups 18-44 years, 45-64 years, and ≥75 years were 12,565, 37,952, and 36,926, respectively, in the year 2020.

Key benefits of the report:

  1. Diabetic Macular Edema market report covers a descriptive overview and comprehensive insight of the Diabetic Macular Edema Epidemiology and Diabetic Macular Edema  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Diabetic Macular Edema market report provides insights on the current and emerging therapies.

  3. Diabetic Macular Edema market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Diabetic Macular Edema market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Diabetic Macular Edema market.

Got queries? Click here to know more about the Diabetic Macular Edema Market Landscape.

Diabetic Macular Edema Overview

Diabetic Macular Edema (DME) is triggered by Diabetic Retinopathy (DR), a well-known complication of diabetes. DR is the most prevalent diabetic eye disease and the leading cause of irreversible blindness in people in their working years in the developed and other developing countries.

Diabetic Macular Edema Market 

The dynamics of the Diabetic Macular Edema market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Novartis, Roche, Kodiak Sciences, Adverum Biotechnologies, Graybug Vision, Ocuphire Pharma, Oxurion, Unity Biotechnology, and others during the forecasted period 2021-2030.

Learn more by requesting for sample @ Diabetic Macular Edema Market Landscape 

Diabetic Macular Edema Pipeline Therapies and Key Companies 

  • Beovu (brolucizumab): Novartis

  • Faricimab: Roche 

  • KSI-301: Kodiak Sciences 

  • ADVM022: Adverum Biotechnologies 

  • GB-102: Graybug Vision

  • APX3330: Ocuphire Pharma 

  • THR-149: Oxurion 

  • UBX1325: Unity Biotechnology 

Diabetic Macular Edema Market Drivers 

  • Increasing changes in lifestyle

  • Personalization of treatment

  • Addressing barriers to screening

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Diabetic Macular Edema Patient Share (%) Overview at a Glance

5. Diabetic Macular Edema Market Overview at a Glance

6. Diabetic Macular Edema Disease Background and Overview

7. Diabetic Macular Edema Epidemiology and Patient Population

8. Country-Specific Patient Population of Diabetic Macular Edema 

9. Diabetic Macular Edema Current Treatment and Medical Practices

10. Unmet Needs

11. Diabetic Macular Edema Emerging Therapies

12. Diabetic Macular Edema Market Outlook

13. Country-Wise Diabetic Macular Edema Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Diabetic Macular Edema Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Diabetic Macular Edema Market Outlook 2030

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/